Indication
Asthma
Assets addressing this indication.
Total attributable cost
$107.9B
$4,333/patient
Drug spend
$45.6B
$1,830/patient
42% of total cost is drugs
All severities, current asthma (2021 estimate) · US
Indication
Assets addressing this indication.
Total attributable cost
$107.9B
$4,333/patient
Drug spend
$45.6B
$1,830/patient
42% of total cost is drugs
All severities, current asthma (2021 estimate) · US
100 of 100 assets